LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.61
-0.09 (-0.93%)
May 29, 2026, 4:08 PM HKT
Market Cap3.33B -52.8%
Revenue (ttm)587.50M +11.9%
Net Income266.77M -2.4%
EPS0.77 -2.6%
Shares Out 346.75M
PE Ratio12.52
Forward PE6.41
Dividend0.58 (6.02%)
Ex-Dividend DateMay 27, 2026
Volume522,189
Open9.92
Previous Close9.70
Day's Range9.59 - 9.94
52-Week Range9.60 - 27.60
Beta-0.19
AnalystsStrong Buy
Price Target30.09 (+211.76%)
Earnings DateAug 21, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices. It operates through Occluder Business and Heart Valve Business segments. The company also researches, develops, manufacture, and sale interventional treatment series occluders for defective congenital heart disease; and manufacture and sale heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent du... [Read more]

Sector Healthcare
Founded 1994
Employees 370
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2291
Full Company Profile

Financial Performance

In 2025, HKG:2291's revenue was 527.94 million, an increase of 11.94% compared to the previous year's 471.64 million. Earnings were 239.73 million, a decrease of -2.37%.

Financial numbers in CNY Financial Statements